That figure is projected to triple by 2030, according to recent data by Grand View Research
If there are signs of repeated use, risky behavior, or withdrawal, professional support is recommended
Comparison of the toxic effects of quinolinic acid and 3-nitropropionic acid in C
Serrano, [email protected] Present address: Joel Vega-Rodrguez, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers